-
Posted: November 1st, 2018, 2:00am GMT
Conditions: Advanced Cutaneous Melanoma of the Extremity; Advanced Sarcoma of the Extremity; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Recurrent Cutaneous Melanoma of the Extremity; Recurrent Sarcoma of the Extremity; Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Interventions: Drug: FACT Complex-targeting Curaxin CBL0137
Sponsors: Roswell Park Cancer Institute; Incuron
Terminated
-
Posted: October 25th, 2018, 2:00am GMT
Conditions: Cutaneous Melanoma, Stage III; Cutaneous Melanoma, Stage IV; Stage III Melanoma; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma; Unresectable Melanoma
Interventions: Drug: Nivolumab; Biological: Rituximab and Hyaluronidase Human; Drug: Ipilimumab
Sponsors: Emory University; Genentech, Inc.
Active, not recruiting
-
Posted: October 9th, 2018, 2:00am GMT
Conditions: Cutaneous Melanoma; Melanocytic Nevus; Skin Carcinoma
Interventions: Other: Confocal Microscopy; Other: Dermoscopy; Procedure: Imaging Technique; Drug: Lidocaine; Procedure: Punch Biopsy; Procedure: Shave Biopsy
Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University
Recruiting
-
Posted: October 5th, 2018, 2:00am GMT
Conditions: Brain Metastases; Glioma of Brain; Brain Tumor; Metastatic Melanoma
Interventions: Device: Dynamic Contrast-Enhanced Magnetic Resonance Imaging; Drug: Bevacizumab Injection
Sponsors: University of Southern California; National Cancer Institute (NCI)
Terminated